Clinical Study
Predictive and Prognostic Factors in Definition of Risk Groups in Endometrial Carcinoma
Table 4
Prognostic factors in endometrial carcinoma.
| (1) FIGO stage (clinical, surgical)* | | (2) Tumor size (>2 cm) | | (3) Histology (endometrioid, nonendometrioid)* | | (4) Myometrial infiltration (>50%)* | | (5) FIGO grade (grade 3 versus 1-2)* | | (6) Nuclear grade (grades 1–3)* | | (7) DNA ploidy (diploid, nondiploid)* | | (8) S-phase fraction | | (9) P53 expression (positive versus negative)* | | (10) ER and PgR expression | | (11) Lymphovascular space invasion (LVSI) | | (12) Age of the patient (>60 years)* | |
|
|
*Factors analysed in the present study.
|